Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis.
The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be > 30 years, both gender.
Diabetes Mellitus, Type 2
|Study Design:||Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
|Official Title:||New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)|
|Study Start Date:||June 1997|
|Study Completion Date:||May 2006|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00520962
|Medicine Division, Diabetology, Endocrinology and Metabolic Disease Unit, IRCCS San Raffaele|
|Milan, Italy, 20132|
|Principal Investigator:||PierMarco Piatti, MD||IRCSS San Raffaele|